Literature DB >> 25419946

Reduced Gray Matter Volume Is Associated With Poorer Instrumental Activities of Daily Living Performance in Heart Failure.

Michael L Alosco1, Adam M Brickman, Mary Beth Spitznagel, Atul Narkhede, Erica Y Griffith, Ronald Cohen, Lawrence H Sweet, Richard Josephson, Joel Hughes, John Gunstad.   

Abstract

BACKGROUND: Heart failure patients require assistance with instrumental activities of daily living in part because of the high rates of cognitive impairment in this population. Structural brain insult (eg, reduced gray matter volume) is theorized to underlie cognitive dysfunction in heart failure, although no study has examined the association among gray matter, cognition, and instrumental activities of daily living in heart failure.
OBJECTIVES: The aim of this study was to investigate the associations among gray matter volume, cognitive function, and functional ability in heart failure.
METHODS: A total of 81 heart failure patients completed a cognitive test battery and the Lawton-Brody self-report questionnaire to assess instrumental activities of daily living. Participants underwent magnetic resonance imaging to quantify total gray matter and subcortical gray matter volume.
RESULTS: Impairments in instrumental activities of daily living were common in this sample of HF patients. Regression analyses controlling for demographic and medical confounders showed that smaller total gray matter volume predicted decreased scores on the instrumental activities of daily living composite, with specific associations noted for medication management and independence in driving. Interaction analyses showed that reduced total gray matter volume interacted with worse attention/executive function and memory to negatively impact instrumental activities of daily living.
CONCLUSIONS: Smaller gray matter volume is associated with greater impairment in instrumental activities of daily living in persons with heart failure, possibly via cognitive dysfunction. Prospective studies are needed to clarify the utility of clinical correlates of gray matter volume (eg, cognitive dysfunction) in identifying heart failure patients at risk for functional decline and determine whether interventions that target improved brain and cognitive function can preserve functional independence in this high-risk population.

Entities:  

Mesh:

Year:  2016        PMID: 25419946      PMCID: PMC4440850          DOI: 10.1097/JCN.0000000000000218

Source DB:  PubMed          Journal:  J Cardiovasc Nurs        ISSN: 0889-4655            Impact factor:   2.083


  44 in total

1.  Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain.

Authors:  Bruce Fischl; David H Salat; Evelina Busa; Marilyn Albert; Megan Dieterich; Christian Haselgrove; Andre van der Kouwe; Ron Killiany; David Kennedy; Shuna Klaveness; Albert Montillo; Nikos Makris; Bruce Rosen; Anders M Dale
Journal:  Neuron       Date:  2002-01-31       Impact factor: 17.173

2.  Regional cortical thinning and cerebrospinal biomarkers predict worsening daily functioning across the Alzheimer's disease spectrum.

Authors:  Gad A Marshall; Natacha Lorius; Joseph J Locascio; Bradley T Hyman; Dorene M Rentz; Keith A Johnson; Reisa A Sperling
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

3.  Cortical surface-based analysis. II: Inflation, flattening, and a surface-based coordinate system.

Authors:  B Fischl; M I Sereno; A M Dale
Journal:  Neuroimage       Date:  1999-02       Impact factor: 6.556

4.  Psychometric evaluation of the Beck Depression Inventory-II with primary care medical patients.

Authors:  R C Arnau; M W Meagher; M P Norris; R Bramson
Journal:  Health Psychol       Date:  2001-03       Impact factor: 4.267

5.  Cerebral atrophy, apolipoprotein E varepsilon4, and rate of decline in everyday function among patients with amnestic mild cognitive impairment.

Authors:  Ozioma C Okonkwo; Michael L Alosco; Beth A Jerskey; Lawrence H Sweet; Brian R Ott; Geoffrey Tremont
Journal:  Alzheimers Dement       Date:  2010-09       Impact factor: 21.566

6.  The FAB: a Frontal Assessment Battery at bedside.

Authors:  B Dubois; A Slachevsky; I Litvan; B Pillon
Journal:  Neurology       Date:  2000-12-12       Impact factor: 9.910

7.  Effect of enalapril maleate on cerebral blood flow in patients with chronic heart failure.

Authors:  H Kamishirado; T Inoue; T Fujito; M Kase; M Shimizu; Y Sakai; K Takayanagi; S Morooka; S Natsui
Journal:  Angiology       Date:  1997-08       Impact factor: 3.619

8.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease.

Authors:  J C Morris; A Heyman; R C Mohs; J P Hughes; G van Belle; G Fillenbaum; E D Mellits; C Clark
Journal:  Neurology       Date:  1989-09       Impact factor: 9.910

9.  Neuroimaging and correlates of cognitive function among patients with heart failure.

Authors:  Raymond L C Vogels; Joukje M Oosterman; Barbera van Harten; Alida A Gouw; Jutta M Schroeder-Tanka; Philip Scheltens; Wiesje M van der Flier; Henry C Weinstein
Journal:  Dement Geriatr Cogn Disord       Date:  2007-10-15       Impact factor: 2.959

10.  Electronically monitored medication adherence predicts hospitalization in heart failure patients.

Authors:  Barbara Riegel; George J Knafl
Journal:  Patient Prefer Adherence       Date:  2013-12-05       Impact factor: 2.711

View more
  5 in total

1.  Management of Cognitive Impairment in Heart Failure.

Authors:  Edlira Yzeiraj; Danny M Tam; Eiran Z Gorodeski
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-01

Review 2.  Dependence and reduced motor function in heart failure: future directions for well-being.

Authors:  Hidetaka Hibino; Stacey L Gorniak
Journal:  Heart Fail Rev       Date:  2021-07-24       Impact factor: 4.654

3.  Cognitive performance is associated with worse prognosis in patients with heart failure with reduced ejection fraction.

Authors:  Patrícia Fino; Rita Matos Sousa; Renata Carvalho; Nuno Sousa; Filipa Almeida; Vítor Hugo Pereira
Journal:  ESC Heart Fail       Date:  2020-08-21

4.  Brain Imaging Changes and Related Risk Factors of Cognitive Impairment in Patients With Heart Failure.

Authors:  Yangyang Jiang; Lei Wang; Ziwen Lu; Shiqi Chen; Yu Teng; Tong Li; Yang Li; Yingzhen Xie; Mingjing Zhao
Journal:  Front Cardiovasc Med       Date:  2022-01-26

Review 5.  The Emerging Role of Combined Brain/Heart Magnetic Resonance Imaging for the Evaluation of Brain/Heart Interaction in Heart Failure.

Authors:  George Markousis-Mavrogenis; Michel Noutsias; Angelos G Rigopoulos; Aikaterini Giannakopoulou; Stergios Gatzonis; Roser Maria Pons; Antigoni Papavasiliou; Vasiliki Vartela; Maria Bonou; Genovefa Kolovou; Constantina Aggeli; Aikaterini Christidi; Flora Bacopoulou; Dimitris Tousoulis; Sophie Mavrogeni
Journal:  J Clin Med       Date:  2022-07-11       Impact factor: 4.964

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.